| Year |
Citation |
Score |
| 2012 |
O'Rourke SM, Schweighardt B, Phung P, Mesa KA, Vollrath AL, Tatsuno GP, To B, Sinangil F, Limoli K, Wrin T, Berman PW. Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodies. Journal of Virology. 86: 12105-14. PMID 22933284 DOI: 10.1128/Jvi.01352-12 |
0.394 |
|
| 2010 |
O'Rourke SM, Schweighardt B, Phung P, Fonseca DP, Terry K, Wrin T, Sinangil F, Berman PW. Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus. Journal of Virology. 84: 11200-9. PMID 20702624 DOI: 10.1128/Jvi.00790-10 |
0.392 |
|
| 2010 |
Euler Z, van Gils MJ, Bunnik EM, Phung P, Schweighardt B, Wrin T, Schuitemaker H. Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. The Journal of Infectious Diseases. 201: 1045-53. PMID 20170371 DOI: 10.1086/651144 |
0.468 |
|
| 2010 |
van Gils MJ, Bunnik EM, Burger JA, Jacob Y, Schweighardt B, Wrin T, Schuitemaker H. Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors. Journal of Virology. 84: 3576-85. PMID 20071586 DOI: 10.1128/JVI.02622-09 |
0.444 |
|
| 2010 |
van Gils MJ, Edo-Matas D, Schweighardt B, Wrin T, Schuitemaker H. High prevalence of neutralizing activity against multiple unrelated human immunodeficiency virus type 1 (HIV-1) subtype B variants in sera from HIV-1 subtype B-infected individuals: evidence for subtype-specific rather than strain-specific neutralizing activity. The Journal of General Virology. 91: 250-8. PMID 19793903 DOI: 10.1099/vir.0.015693-0 |
0.425 |
|
| 2009 |
van Gils MJ, Euler Z, Schweighardt B, Wrin T, Schuitemaker H. Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression. Aids (London, England). 23: 2405-14. PMID 19770692 DOI: 10.1097/QAD.0b013e32833243e7 |
0.436 |
|
| 2009 |
O'Rourke SM, Schweighardt B, Scott WG, Wrin T, Fonseca DP, Sinangil F, Berman PW. Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies. Journal of Virology. 83: 7728-38. PMID 19474108 DOI: 10.1128/Jvi.00688-09 |
0.326 |
|
| 2009 |
Schweighardt B, Ma Z, Petropoulos CJ, Miller CJ, Wrin T. P04-47. High-titer autologous and heterologous neutralizing antibody activity in acute SIV-infection Retrovirology. 6: P75. DOI: 10.1186/1742-4690-6-S3-P75 |
0.471 |
|
| 2009 |
Van Gils MJ, Euler Z, Schweighardt B, Wrin T, Schuitemaker H. P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression Retrovirology. 6: P390. DOI: 10.1186/1742-4690-6-S3-P390 |
0.404 |
|
| 2007 |
Schweighardt B, Liu Y, Huang W, Chappey C, Lie YS, Petropoulos CJ, Wrin T. Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individuals. Journal of Acquired Immune Deficiency Syndromes (1999). 46: 1-11. PMID 17514017 DOI: 10.1097/QAI.0b013e318074eb5a |
0.363 |
|
| 2007 |
Streeck H, Schweighardt B, Jessen H, Allgaier RL, Wrin T, Stawiski EW, Jessen AB, Allen TM, Walker BD, Altfeld M. Loss of HIV-1-specific T-cell responses associated with very rapid HIV-1 disease progression. Aids (London, England). 21: 889-91. PMID 17415054 DOI: 10.1097/Qad.0B013E3280F77439 |
0.363 |
|
| 2006 |
Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, Sinclair E, Hunt P, McCune JM, Martin JN, Petropoulos CJ, Hecht FM. Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. Journal of Virology. 80: 6155-64. PMID 16731954 DOI: 10.1128/JVI.00093-06 |
0.492 |
|
| 2005 |
Roy AM, Schweighardt B, Eckstein LA, Goldsmith MA, McCune JM. Enhanced replication of R5 HIV-1 over X4 HIV-1 in CD4(+)CCR5(+)CXCR4(+) T cells. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 267-75. PMID 16249699 DOI: 10.1097/01.Qai.0000176593.14172.52 |
0.536 |
|
| 2004 |
Schweighardt B, Roy AM, Meiklejohn DA, Grace EJ, Moretto WJ, Heymann JJ, Nixon DF. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1. Journal of Virology. 78: 9164-73. PMID 15308712 DOI: 10.1128/JVI.78.17.9164-9173.2004 |
0.512 |
|
| 2003 |
Alexander TH, Ortiz GM, Wellons MF, Allen A, Grace EJ, Schweighardt B, Brancato J, Sandberg JK, Furlan SN, Miralles GD, Nixon DF, Bartlett JA. Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999). 34: 475-81. PMID 14657757 DOI: 10.1097/00126334-200312150-00005 |
0.377 |
|
| 2002 |
Schweighardt B, Ortiz GM, Grant RM, Wellons M, Miralles GD, Kostrikis LG, Bartlett JA, Nixon DF. Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions. Aids (London, England). 16: 2342-4. PMID 12441810 DOI: 10.1097/00002030-200211220-00018 |
0.341 |
|
| 2001 |
Schweighardt B, Atwood WJ. Glial cells as targets of viral infection in the human central nervous system. Progress in Brain Research. 132: 721-35. PMID 11545031 DOI: 10.1016/S0079-6123(01)32113-1 |
0.569 |
|
| 2001 |
Schweighardt B, Atwood WJ. HIV type 1 infection of human astrocytes is restricted by inefficient viral entry. Aids Research and Human Retroviruses. 17: 1133-42. PMID 11522183 DOI: 10.1089/088922201316912745 |
0.592 |
|
| 2001 |
Schweighardt B, Atwood WJ. Virus receptors in the human central nervous system. Journal of Neurovirology. 7: 187-95. PMID 11517393 DOI: 10.1080/13550280152403236 |
0.506 |
|
| 2001 |
Schweighardt B, Shieh JT, Atwood WJ. CD4/CXCR4-independent infection of human astrocytes by a T-tropic strain of HIV-1. Journal of Neurovirology. 7: 155-62. PMID 11517388 DOI: 10.1080/13550280152058816 |
0.581 |
|
| Show low-probability matches. |